Oral contraceptives have long been considered an option to treat anovulatory infertility in PCOS by reducing LH and androgen plasma levels, restoring normal and adequate spontaneous episodic gonadotropin discharge, decreasing ovarian volumes and regularizing menstrual cycles for planning ovulation induction programs (26, 27). Here, PLOD1 is linked to polycystic ovary syndrome.